Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bing Jia

Showing results (171-180 of 292) with videos related to

Pageof 30
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
Longitudinal monitoring of tumor antiangiogenic therapy with near-infrared fluorophore-labeled agents targeted to integrin αvβ3 and vascular endothelial growth factorXianlei Sun, Teng Ma, Hao Liu, et al.
Molecular Pharmaceutics|August 27, 2014
PET imaging of neovascularization with (68)Ga-3PRGD2 for assessing tumor early response to Endostar antiangiogenic therapyJiyun Shi, Zhongxia Jin, Xujie Liu, et al.
Neuroreport|May 7, 2004
Radionuclide imaging of mesenchymal stem cells transplanted into spinal cordJinzhu Bai, Weimin Ding, Minjun Yu, et al.
Molecular Imaging|June 14, 2013
Technetium 99m-labeled VQ peptide: a new imaging agent for the early detection of tumors or premalignanciesJiyun Shi, Liyang Cui, Bing Jia, et al.
Biomacromolecules|July 3, 2015
Polymer-Doxorubicin Conjugate Micelles Based on Poly(ethylene glycol) and Poly(N-(2-hydroxypropyl) methacrylamide): Effect of Negative Charge and Molecular Weight on Biodistribution and Blood ClearanceQingsong Yu, Zhenke Wei, Jiyun Shi, et al.
Journal for Immunotherapy of Cancer|November 18, 2020
Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapyHannan Gao, Yue Wu, Jiyun Shi, et al.
Bioconjugate Chemistry|June 10, 2022
IgG-Binding Nanobody Capable of Prolonging Nanobody-Based Radiotracer Plasma Half-Life and Enhancing the Efficacy of Tumor-Targeted Radionuclide TherapyBiao Hu, Tianyu Liu, Liqiang Li, et al.
Geriatrics & Gerontology International|March 3, 2015
Downregulation of miR-146a, cyclooxygenase-2 and advanced glycation end-products in simvastatin-treated older patients with hyperlipidemiaZhou Xin Yang, Ya Zhen Wang, Bing Bing Jia, et al.
Molecular Pharmaceutics|January 30, 2014
177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma modelZhaofei Liu, Teng Ma, Hao Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 30, 2024
Nuclear imaging of PD-L1 expression promotes the synergistic antitumor efficacy of targeted radionuclide therapy and immune checkpoint blockadeJiyun Shi, Hannan Gao, Yue Wu, et al.
Pageof 30

Showing results (171-180 of 292) with videos related to

Sort By:
Pageof 30
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
Longitudinal monitoring of tumor antiangiogenic therapy with near-infrared fluorophore-labeled agents targeted to integrin αvβ3 and vascular endothelial growth factorXianlei Sun, Teng Ma, Hao Liu, et al.
Molecular Pharmaceutics|August 27, 2014
PET imaging of neovascularization with (68)Ga-3PRGD2 for assessing tumor early response to Endostar antiangiogenic therapyJiyun Shi, Zhongxia Jin, Xujie Liu, et al.
Neuroreport|May 7, 2004
Radionuclide imaging of mesenchymal stem cells transplanted into spinal cordJinzhu Bai, Weimin Ding, Minjun Yu, et al.
Molecular Imaging|June 14, 2013
Technetium 99m-labeled VQ peptide: a new imaging agent for the early detection of tumors or premalignanciesJiyun Shi, Liyang Cui, Bing Jia, et al.
Biomacromolecules|July 3, 2015
Polymer-Doxorubicin Conjugate Micelles Based on Poly(ethylene glycol) and Poly(N-(2-hydroxypropyl) methacrylamide): Effect of Negative Charge and Molecular Weight on Biodistribution and Blood ClearanceQingsong Yu, Zhenke Wei, Jiyun Shi, et al.
Journal for Immunotherapy of Cancer|November 18, 2020
Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapyHannan Gao, Yue Wu, Jiyun Shi, et al.
Bioconjugate Chemistry|June 10, 2022
IgG-Binding Nanobody Capable of Prolonging Nanobody-Based Radiotracer Plasma Half-Life and Enhancing the Efficacy of Tumor-Targeted Radionuclide TherapyBiao Hu, Tianyu Liu, Liqiang Li, et al.
Geriatrics & Gerontology International|March 3, 2015
Downregulation of miR-146a, cyclooxygenase-2 and advanced glycation end-products in simvastatin-treated older patients with hyperlipidemiaZhou Xin Yang, Ya Zhen Wang, Bing Bing Jia, et al.
Molecular Pharmaceutics|January 30, 2014
177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma modelZhaofei Liu, Teng Ma, Hao Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 30, 2024
Nuclear imaging of PD-L1 expression promotes the synergistic antitumor efficacy of targeted radionuclide therapy and immune checkpoint blockadeJiyun Shi, Hannan Gao, Yue Wu, et al.
Pageof 30